Characteristic | Patients | |||
---|---|---|---|---|
All | LC | CRC | Other | |
(n = 30) | (n = 15) | (n = 10) | (n = 5) | |
Sputum smear, n (%) | ||||
 Negative | 10 (33.3) | 5 (33.3) | 3 (30.0) | 2 (40.0) |
 Positive | 20 (66.7) | 10 (66.7) | 7 (70.0) | 3 (60.0) |
PCR/LAMP, n (%) | ||||
 Negative | 1 (3.3) | 1 (6.7) | 0 (0.0) | 0 (0.0) |
 Positive | 15 (50.0) | 10 (66.7) | 3 (30.0) | 2 (40.0) |
 Unknown | 14 (46.7) | 4 (26.7) | 7 (70.0) | 3 (60.0) |
Culture, n (%) | ||||
 Negative | 5 (16.7) | 3 (20.0) | 2 (20.0) | 0 (0.0) |
 Positive | 25 (83.3) | 12 (80.0) | 8 (80.0) | 5 (100.0) |
Sensitivity to anti-MTB agents, n (%) | ||||
 Sensitive | 22 (88.0) | 12 (100.0) | 6 (75.0) | 4 (80.0) |
 Resistant | 2 (8.0)a | 0 (0.0) | 2 (25.0) | 0 (0.0) |
 Unknown | 1 (4.0)b | 0 (0.0) | 0 (0.0) | 1 (20.0)b |
Time until the result of Bacteriological Examination come out | ||||
 | Overall | Ogawa-Kudoh | MGIT | |
Time to MTB-positive culture (days), mean ± SD, n | 20.9 ± 12.4 (n=23c) | 37.6 ± 8.4 (n = 5) | 16.2 ± 8.7* (n = 18) | |
Time to sensitivity testing (days), mean ± SD, n | 12.6 ± 3.5 (n=22d) |  |  |